Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Avangrid $AGR broke through resistance at $46.52 after previously being capped at $44.02. The surge in volume to 85.92 million shares, significantly above its average of 11.01 million, confirms strong buying interest. This kind of volume expansion often validates a breakout and suggests that momentum traders are stepping in.
CME Group ($CME) crossed above its $262.28 resistance level, overcoming its prior cap at $256.88. Volume nearly doubled, reaching 3.56 million shares compared to an average of 1.81 million. While the breakout looks strong, analysts remain divided on the stock’s long-term prospects due to concerns about return on invested capital and concentration risk.
ENGlobal ($ENG) cleared resistance at $13.19 after struggling to break above $12.74. The move was accompanied by a volume spike to 2.11 million shares, more than double its average. With such an increase in trading activity, this breakout has the potential to hold as traders seek follow-through momentum.
Ford ($F) pushed past its previous resistance of $9.82, reaching a new high of $9.96. Trading volume surged to 159.77 million shares, far exceeding its average of 96.51 million. This suggests strong institutional interest, which could provide further support for an extended move higher.
Paychex ($PAYX) also joined the breakout club, surpassing $154.52 after holding at $153.37 for a while. The stock saw a notable increase in volume, trading 3.13 million shares compared to its usual 1.77 million. Sustained momentum above this level could attract more buyers looking for confirmation of an uptrend.
PACCAR ($PCAR) climbed above $110.56, breaking past its previous resistance at $108.04. With trading volume nearly doubling to 4.86 million, compared to an average of 2.61 million, this breakout has the potential for further gains, especially if industrial stocks continue to attract investor interest.
Protagonist Therapeutics ($PTGX) saw an explosive move past $55.95 after previously topping out at $41.42. With volume soaring to 4.96 million shares—well above the 807.82K average—momentum is clearly in its favor. This kind of strength could indicate further upside if buyers remain in control.
Redfin ($RDFN) had a massive breakout to $9.77, shattering its old resistance at $8.99. The stock’s 92.05 million share volume is an eye-popping increase from its 6.78 million average, fueled by news of Rocket Companies’ $1.75 billion acquisition deal. M&A-driven breakouts often create extended moves, especially if investors view the deal favorably.
Regeneron Pharmaceuticals ($REGN) surged to $744.83, eyeing a further breakout toward its next resistance at $785.03. Previously, the stock faced resistance at $723.47, but its volume of 1.61 million shares—well above the 917.58K average—suggests that buyers are in control.
Science Applications International ($SAIC) jumped to $111.51 after previously struggling to break $110.57. The stock is now targeting a breakout above $121.96.
SBA Communications ($SBAC) edged past its $221.51 resistance level to close at $224.91, with volume picking up to 1.26 million shares against an average of 803K.
TG Therapeutics ($TGTX) also moved higher, breaking past $39.23 after facing resistance at $35.62.
Trevi Therapeutics ($TRVI) had a strong breakout to $6.07, smashing its previous resistance at $4.80. The move was supported by positive clinical trial results, which drove a significant volume surge to 56.83 million shares—far exceeding its 809.69K average.
Xeris Biopharma ($XERS) completed the list of breakout stocks, pushing past $4.59 after being held back at $4.13.
Join StocksRunner.com for daily market updates, expert analyses, and actionable insights.
Signup now for FREE and stay ahead of the market curve!
Find out what 10,000+ subscribers already know.
Real-time insights for informed decisions.
Limited slots available, SignUp Now!
Please note that the content above should not be considered as investment advice or marketing. It does not take into account the personal data and requirements of any individual. This content is not a substitute for the reader's own judgment and should not be considered as advice or a recommendation for buying or selling any securities or financial products.
Get all the pieces of the puzzle on important data activity before the major news sources break the story and find out what happening right now and what could happen in the future
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Real-time stock market updates
Expert stock analysis
Investment strategies
Top stock recommendations
Trading signals and opportunities
Discover what is happening right now and piece together the key data activity before the major news outlets catch on. Stay ahead of the trends
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
The Score performance whether actual or indicated by historical tests of strategies, is no guarantee of future performance or success. The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained.
The results reflect performance of a strategy not historically offered to investors and does not represent returns that any investor actually attained. The Readiness Indicators, Sentiment Indicators and total score are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Active trading is generally not appropriate for someone of limited resources, limited invesment or trading experience, or low-risk tolerance. Your capital may be at risk.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.